Concepedia

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial

Craig B. Reeder, Donna Reece, Vishal Kukreti, Christine Chen, Suzanne Trudel, Joseph G. Hentz, Brie N. Noble, Nicholas Pirooz, Jacy Spong, J Píza,

Leukemia · 2009 · 371 citations · 30 references

DOIFull text

Open access

Concepts

References

30

International Staging System for Multiple Myeloma

Philip R. Greipp, Jesús F. San Miguel, Brian G.M. Durie et al. · Journal of Clinical Oncology · 2005 · 2.9K citations

, , +14

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

, , +12

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Seema Singhal, Jayesh Mehta, Raman Desikan et al. · New England Journal of Medicine · 1999 · 2.6K citations · Full text

, , +14

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

, , +14

Improved survival in multiple myeloma and the impact of novel therapies

Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri et al. · Blood · 2007 · 2.3K citations · Full text

, , +14